Current information about vaccination practice in pediatric rheumatic diseases and recommendations for future...

Area of Science:

• Pediatric Rheumatology
• Immunology
• Vaccinology

Background:

• Pediatric patients with autoinflammatory or rheumatic diseases face heightened infection risks.
• Immunosuppressive drugs and biological agents used in treatment further increase susceptibility to infections.
• Effective and safe vaccination is critical for managing these vulnerable patients.

Purpose of the Study:

• To review current vaccination practices for pediatric rheumatic diseases.
• To provide recommendations for future vaccination applications in this population.
• To address the complexities of vaccine immunogenicity and safety in immunocompromised children.

Main Methods:

• Literature review of current vaccination guidelines and research.
• Analysis of vaccine immunogenicity in pediatric rheumatic disease patients compared to healthy individuals.
• Evaluation of the safety of different vaccine types (live attenuated vs. inactivated) in relation to immunosuppressive therapies.

Main Results:

• Live attenuated vaccines are generally contraindicated in patients receiving high-dose immunosuppressive drugs.
• Inactivated vaccines are typically safe for patients with rheumatic diseases.
• The immunomodulatory effects of biologic agents necessitate careful timing of live virus vaccinations post-treatment.

Conclusions:

• Vaccination is essential but requires tailored strategies in pediatric rheumatic diseases.
• Careful consideration of the patient's disease status and immunosuppressive therapy is crucial for vaccine selection and timing.
• Future applications should focus on optimizing vaccine efficacy and safety in this high-risk group.